世界のサクサグリプチン市場レポート2020年

【英語タイトル】Global Saxagliptin Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB12782)・商品コード:QYR21FB12782
・発行会社(調査会社):QYResearch
・発行日:2021年1月
・ページ数:138
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,120,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のサクサグリプチン市場について種類別(2.5mg、5mg)、用途別(2型糖尿病、用途2)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・サクサグリプチン市場の概要
・世界の主要地域別サクサグリプチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のサクサグリプチン市場規模2015-2026:種類別(2.5mg、5mg)
・世界のサクサグリプチン市場規模2015-2026:用途別(2型糖尿病、用途2)
・サクサグリプチンのアメリカ市場規模2015-2020
・サクサグリプチンのヨーロッパ市場規模2015-2020
・サクサグリプチンの中国市場規模2015-2020
・サクサグリプチンの日本市場規模2015-2020
・サクサグリプチンの東南アジア市場規模2015-2020
・サクサグリプチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・サクサグリプチンの製造コスト分析
・販売チャネル、流通業者、顧客
・サクサグリプチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Saxagliptin Market
The global Saxagliptin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Saxagliptin Scope and Market Size
The global Saxagliptin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Saxagliptin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Saxagliptin market is segmented into
2.5mg
5mg

Segment by Application, the Saxagliptin market is segmented into
Type 2 Diabetes
Application 2

The Saxagliptin market is analysed and market size information is provided by regions (countries). Segment by Application, the Saxagliptin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Saxagliptin Market Share Analysis
Saxagliptin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Saxagliptin business, the date to enter into the Saxagliptin market, Saxagliptin product introduction, recent developments, etc.

The major vendors covered:
Bristol-Myers Squibb Company
AstraZeneca

【レポートの目次】

1 Saxagliptin Market Overview
1.1 Saxagliptin Product Scope
1.2 Saxagliptin Segment by Type
1.2.1 Global Saxagliptin Sales by Type (2020-2026)
1.2.2 2.5mg
1.2.3 5mg
1.3 Saxagliptin Segment by Application
1.3.1 Global Saxagliptin Sales Comparison by Application (2020-2026)
1.3.2 Type 2 Diabetes
1.3.3 Application 2
1.4 Saxagliptin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Saxagliptin Sales Growth Rate (2015-2026)
1.4.2 Global Saxagliptin Revenue and Growth Rate (2015-2026)
1.4.3 Global Saxagliptin Price Trends (2015-2026)

2 Saxagliptin Estimate and Forecast by Region
2.1 Global Saxagliptin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Saxagliptin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Saxagliptin Sales Market Share by Region (2015-2020)
2.2.2 Global Saxagliptin Revenue Market Share by Region (2015-2020)
2.3 Global Saxagliptin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Saxagliptin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Saxagliptin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Saxagliptin Estimates and Projections (2015-2026)
2.4.2 Europe Saxagliptin Estimates and Projections (2015-2026)
2.4.3 China Saxagliptin Estimates and Projections (2015-2026)
2.4.4 Japan Saxagliptin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Saxagliptin Estimates and Projections (2015-2026)
2.4.6 India Saxagliptin Estimates and Projections (2015-2026)
3 Global Saxagliptin Competition Landscape by Players
3.1 Global Top Saxagliptin Players by Sales (2015-2020)
3.2 Global Top Saxagliptin Players by Revenue (2015-2020)
3.3 Global Saxagliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Saxagliptin as of 2019)
3.4 Global Saxagliptin Average Price by Company (2015-2020)
3.5 Manufacturers Saxagliptin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Saxagliptin Players (Opinion Leaders)
4 Global Saxagliptin Market Size by Type
4.1 Global Saxagliptin Historic Market Review by Type (2015-2020)
4.1.1 Global Saxagliptin Sales Market Share by Type (2015-2020)
4.1.2 Global Saxagliptin Revenue Market Share by Type (2015-2020)
4.1.3 Global Saxagliptin Price by Type (2015-2020)
4.2 Global Saxagliptin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Saxagliptin Sales Forecast by Type (2021-2026)
4.2.2 Global Saxagliptin Revenue Forecast by Type (2021-2026)
4.2.3 Global Saxagliptin Price Forecast by Type (2021-2026)
5 Global Saxagliptin Market Size by Application
5.1 Global Saxagliptin Historic Market Review by Application (2015-2020)
5.1.1 Global Saxagliptin Sales Market Share by Application (2015-2020)
5.1.2 Global Saxagliptin Revenue Market Share by Application (2015-2020)
5.1.3 Global Saxagliptin Price by Application (2015-2020)
5.2 Global Saxagliptin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Saxagliptin Sales Forecast by Application (2021-2026)
5.2.2 Global Saxagliptin Revenue Forecast by Application (2021-2026)
5.2.3 Global Saxagliptin Price Forecast by Application (2021-2026)

6 United States Saxagliptin Market Facts & Figures
6.1 United States Saxagliptin Sales Market Share by Company (2015-2020)
6.2 United States Saxagliptin Sales Market Share by Type (2015-2020)
6.3 United States Saxagliptin Sales Market Share by Application (2015-2020)

7 Europe Saxagliptin Market Facts & Figures
7.1 Europe Saxagliptin Sales Market Share by Company (2015-2020)
7.2 Europe Saxagliptin Sales Market Share by Type (2015-2020)
7.3 Europe Saxagliptin Sales Market Share by Application (2015-2020)

8 China Saxagliptin Market Facts & Figures
8.1 China Saxagliptin Sales Market Share by Company (2015-2020)
8.2 China Saxagliptin Sales Market Share by Type (2015-2020)
8.3 China Saxagliptin Sales Market Share by Application (2015-2020)

9 Japan Saxagliptin Market Facts & Figures
9.1 Japan Saxagliptin Sales Market Share by Company (3015-3030)
9.2 Japan Saxagliptin Sales Market Share by Type (2015-2020)
9.3 Japan Saxagliptin Sales Market Share by Application (2015-2020)

10 Southeast Asia Saxagliptin Market Facts & Figures
10.1 Southeast Asia Saxagliptin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Saxagliptin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Saxagliptin Sales Market Share by Application (2015-2020)

11 India Saxagliptin Market Facts & Figures
11.1 India Saxagliptin Sales Market Share by Company (2015-2020)
11.2 India Saxagliptin Sales Market Share by Type (2015-2020)
11.3 India Saxagliptin Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Saxagliptin Business
12.1 Bristol-Myers Squibb Company
12.1.1 Bristol-Myers Squibb Company Corporation Information
12.1.2 Bristol-Myers Squibb Company Business Overview
12.1.3 Bristol-Myers Squibb Company Saxagliptin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol-Myers Squibb Company Saxagliptin Products Offered
12.1.5 Bristol-Myers Squibb Company Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Saxagliptin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca Saxagliptin Products Offered
12.2.5 AstraZeneca Recent Development

13 Saxagliptin Manufacturing Cost Analysis
13.1 Saxagliptin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Saxagliptin
13.4 Saxagliptin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Saxagliptin Distributors List
14.3 Saxagliptin Customers

15 Market Dynamics
15.1 Saxagliptin Market Trends
15.2 Saxagliptin Opportunities and Drivers
15.3 Saxagliptin Market Challenges
15.4 Saxagliptin Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Saxagliptin Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Saxagliptin Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Saxagliptin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Saxagliptin Sales (K Units) by Region (2015-2020)
Table 5. Global Saxagliptin Sales Market Share by Region (2015-2020)
Table 6. Global Saxagliptin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Saxagliptin Revenue Share by Region (2015-2020)
Table 8. Global Saxagliptin Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Saxagliptin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Saxagliptin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Saxagliptin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Saxagliptin (K Units) of Key Companies (2015-2020)
Table 13. Global Saxagliptin Sales Share by Company (2015-2020)
Table 14. Global Saxagliptin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Saxagliptin Revenue Share by Company (2015-2020)
Table 16. Global Saxagliptin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Saxagliptin as of 2019)
Table 17. Global Saxagliptin Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Saxagliptin Manufacturing Sites and Area Served
Table 19. Manufacturers Saxagliptin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Saxagliptin Players
Table 22. Global Saxagliptin Sales (K Units) by Type (2015-2020)
Table 23. Global Saxagliptin Sales Share by Type (2015-2020)
Table 24. Global Saxagliptin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Saxagliptin Price (K Units) by Type (2015-2020)
Table 26. Global Saxagliptin Sales Share by Type (2021-2026)
Table 27. Global Saxagliptin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Saxagliptin Revenue Share by Type (2021-2026)
Table 29. Global Saxagliptin Price (K Units) by Type (2021-2026)
Table 30. Global Saxagliptin Sales (K Units) by Application (2015-2020)
Table 31. Global Saxagliptin Sales Share by Application (2015-2020)
Table 32. Global Saxagliptin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Saxagliptin Price (K Units) by Application (2015-2020)
Table 34. Global Saxagliptin Sales (K Units) by Application (2021-2026)
Table 35. Global Saxagliptin Sales Share by Application (2021-2026)
Table 36. Global Saxagliptin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Saxagliptin Revenue Share by Application (2021-2026)
Table 38. Global Saxagliptin Price (K Units) by Application (2021-2026)
Table 39. United States Saxagliptin Sales (K Units) by Company (2015-2020)
Table 40. United States Saxagliptin Sales Market Share by Company (2015-2020)
Table 41. United States Saxagliptin Sales (K Units) by Type (2015-2020)
Table 42. United States Saxagliptin Sales Market Share by Type (2015-2020)
Table 43. United States Saxagliptin Sales (K Units) by Application (2015-2020)
Table 44. United States Saxagliptin Sales Market Share by Application (2015-2020)
Table 45. Europe Saxagliptin Sales (K Units) by Company (2015-2020)
Table 46. Europe Saxagliptin Sales Market Share by Company (2015-2020)
Table 47. Europe Saxagliptin Sales (K Units) by Type (2015-2020)
Table 48. Europe Saxagliptin Sales Market Share by Type (2015-2020)
Table 49. Europe Saxagliptin Sales (K Units) by Application (2015-2020)
Table 50. Europe Saxagliptin Sales Market Share by Type (2015-2020)
Table 51. China Saxagliptin Sales (K Units) by Company (2015-2020)
Table 52. China Saxagliptin Sales Market Share by Company (2015-2020)
Table 53. China Saxagliptin Sales (K Units) by Type (2015-2020)
Table 54. China Saxagliptin Sales Market Share by Type (2015-2020)
Table 55. China Saxagliptin Sales (K Units) by Application (2015-2020)
Table 56. China Saxagliptin Sales Market Share by Application (2015-2020)
Table 57. Japan Saxagliptin Sales (K Units) by Company (2015-2020)
Table 58. Japan Saxagliptin Sales Market Share by Company (2015-2020)
Table 59. Japan Saxagliptin Sales (K Units) by Type (2015-2020)
Table 60. Japan Saxagliptin Sales Market Share by Type (2015-2020)
Table 61. Japan Saxagliptin Sales (K Units) by Application (2015-2020)
Table 62. Japan Saxagliptin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Saxagliptin Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Saxagliptin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Saxagliptin Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Saxagliptin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Saxagliptin Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Saxagliptin Sales Market Share by Application (2015-2020)
Table 69. India Saxagliptin Sales (K Units) by Company (2015-2020)
Table 70. India Saxagliptin Sales Market Share by Company (2015-2020)
Table 71. India Saxagliptin Sales (K Units) by Type (2015-2020)
Table 72. India Saxagliptin Sales Market Share by Type (2015-2020)
Table 73. India Saxagliptin Sales (K Units) by Application (2015-2020)
Table 74. India Saxagliptin Sales Market Share by Application (2015-2020)
Table 75. Bristol-Myers Squibb Company Corporation Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company Saxagliptin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Company Saxagliptin Product
Table 79. Bristol-Myers Squibb Company Recent Development
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Saxagliptin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AstraZeneca Saxagliptin Product
Table 84. AstraZeneca Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Saxagliptin Distributors List
Table 88. Saxagliptin Customers List
Table 89. Saxagliptin Market Key Trends
Table 90. Saxagliptin Key Opportunities and Drivers
Table 91. Saxagliptin Market Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Saxagliptin Product Picture
Figure 2. Global Saxagliptin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Saxagliptin Market Share by Application in 2020 & 2026
Figure 6. Type 2 Diabetes Examples
Figure 7. Application 2 Examples
Figure 8. Global Saxagliptin Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Saxagliptin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Saxagliptin Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Saxagliptin Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Saxagliptin Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Saxagliptin Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Saxagliptin Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Saxagliptin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Saxagliptin Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Saxagliptin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Saxagliptin Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Saxagliptin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Saxagliptin Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Saxagliptin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Saxagliptin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Saxagliptin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Saxagliptin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Saxagliptin Players Market Share by Revenue in Saxagliptin 2015 & 2019
Figure 26. Saxagliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Saxagliptin Revenue Share by Type (2015-2020)
Figure 28. Global Saxagliptin Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Saxagliptin Revenue Share by Application (2015-2020)
Figure 30. Global Saxagliptin Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Saxagliptin Sales Market Share by Type in 2019
Figure 32. United States Saxagliptin Sales Market Share by Type in 2019
Figure 33. Europe Saxagliptin Sales Market Share by Company in 2019
Figure 34. Europe Saxagliptin Sales Market Share by Type in 2019
Figure 35. Europe Saxagliptin Sales Market Share by Application in 2019
Figure 36. China Saxagliptin Sales Market Share by Company in 2019
Figure 37. China Saxagliptin Sales Market Share by Type in 2019
Figure 38. China Saxagliptin Sales Market Share by Application in 2019
Figure 39. Japan Saxagliptin Sales Market Share by Company in 2019
Figure 40. Japan Saxagliptin Sales Market Share by Type in 2019
Figure 41. Japan Saxagliptin Sales Market Share by Application in 2019
Figure 42. Southeast Asia Saxagliptin Sales Market Share by Company in 2019
Figure 43. Southeast Asia Saxagliptin Sales Market Share by Type in 2019
Figure 44. Southeast Asia Saxagliptin Sales Market Share by Application in 2019
Figure 45. India Saxagliptin Sales Market Share by Company in 2019
Figure 46. India Saxagliptin Sales Market Share by Type in 2019
Figure 47. India Saxagliptin Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Saxagliptin
Figure 50. Manufacturing Process Analysis of Saxagliptin
Figure 51. Saxagliptin Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed


【掲載企業】

Bristol-Myers Squibb Company、AstraZeneca

★調査レポート[世界のサクサグリプチン市場レポート2020年] (コード:QYR21FB12782)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のサクサグリプチン市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆